Showing 8981-8990 of 20877 results for "".
Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-immune-checkpoint-inhibitor-colitis-effectively/32873/Immune checkpoint inhibitor (ICI) colitis comes with unique diagnostic and treatment challenges, which means that recognizing and managing it effectively is key to the best outcomes. Joining Dr. Peter Buch to share her insights on caring for patients with this complex condition is Dr. Yinghong Wang.Exploring Technological Advances in GI Training: Practical Insights for Clinicians
https://reachmd.com/programs/gi-insights/exploring-technological-advances-in-gi-training-practical-insights-for-clinicians/32875/Artificial intelligence, simulation platforms, augmented reality, and other technological innovations are transforming our approach to GI training. In this expert-led discussion, Dr. Peter Buch sits down with Dr. Nabil Mansour to discuss how we can integrate cutting-edge tools into colonoscopy trainDermwireTV: DermaRite Issues Recall for Several Hand Soaps
https://reachmd.com/videos/dermwire-tv/dermwiretv-dermarite-issues-recall-for-several-hand-soaps/37113/In this episode, new research shows switching between interclass biologics may be safe and effective for psoriasis patients; DermaRite recalls 4 skin care products over contamination concerns; and awareness grows for generalized pustular psoriasis through a new global awareness campaign.Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
https://reachmd.com/programs/project-oncology/are-subcutaneous-immunotherapies-expanding-access-and-efficiency-in-cancer-care/36401/Subcutaneous immunotherapies are emerging as a promising alternative to traditional IV delivery for immune checkpoint inhibitors, demonstrating comparable safety and efficacy along with meaningful time savings. But reimbursement gaps, dosing complexities, and biosimilar competition present challengeAdvances in Pediatric Eczema Care: Emerging Biologics, JAK Inhibitors, and Beyond
https://reachmd.com/programs/dermconsult/advances-in-pediatric-eczema-care-emerging-biologics-jak-inhibitors-and-beyond/35500/Between four FDA-approved biologics, two oral JAK inhibitors, and an exciting pipeline that features novel therapies and extended dosing innovations, the treatment of pediatric eczema is rapidly evolving. Catch up on the latest updates and where the landscape is headed with Dr. Peter Lio, Clinical AImproving Surgical Outcomes: Strategies to Prevent Wound Complications
https://reachmd.com/programs/clinicians-roundtable/improving-surgical-outcomes-strategies-to-prevent-wound-complications/35838/Postsurgical wound complications can drastically impact patient outcomes, lead to preventable readmissions, and drive up healthcare costs. Hear from Dr. Karen Bauer as she explores the multifactorial risks that increase susceptibility to wound dehiscence and infection and provides proactive strategiInvestigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
https://reachmd.com/programs/project-oncology/investigating-at-home-subcutaneous-atezolizumab-for-nsclc-an-ongoing-study/35769/Can the immune checkpoint inhibitor atezolizumab be safely administered subcutaneously at home for patients with non-small cell lung cancer (NSCLC)? That’s the exact question an ongoing study is seeking to answer, and here to discuss the study’s objective, design, and potential implications for homeAdvancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
https://reachmd.com/programs/frontlines-cidp/advancing-cidp-research-targeted-therapies-ai-integration-and-immunological-insights/33069/From innovative diagnostic strategies to targeted immunotherapies, our approach to chronic inflammatory demyelinating polyneuropathy (CIDP) management is rapidly evolving. Dr. Karissa Gable, Assistant Professor of Neurology at Duke University Medical Center, breaks down the new developments that aimFuture Directions in Psoriasis Treatment: Innovations and Implications
https://reachmd.com/programs/frontlines-psoriasis/future-directions-in-psoriasis-treatment-innovations-and-implications/32439/Dr. Andrew Blauvelt shares his insights on the evolving treatment landscape for psoriasis, from novel oral therapies to biologic injections.Acute Ischemic Stroke in the Third Trimester of Pregnancy: A Case of Successful Treatment with Tenecteplase and Thrombectomy
https://reachmd.com/diseases-diagnoses/stroke/acute-ischemic-stroke-in-the-third-trimester-of-pregnancy-a-case-of-successful-treatment-with-tenecteplase-and-thrombectomy/35560/The authors present a case of ischemic stroke in an individual in the third trimester of pregnancy, with favorable outcomes for both the mother and infant resulting from treatment with both tenecteplase and thrombectomy.